MNS
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-78263-200 mg |
| CAS # | 1485-00-3 |
| Pricing | 200 mg, USD $80.0 |
| Biological Activity | MNS (NSC 170724), the beta-nitrostyrene derivative, is a potent tyrosine kinase inhibitor and a broad-spectrum antiplatelet agent. MNS completely inhibits U46619, ADP-, arachidonic acid-, collagen-, and thrombin-induced platelet aggregation with IC50 values of 2.1, 4.1, 5.8, 7.0, and 12.7 μM, respectively. MNS inhibits Src, Syk, and FAK with IC50 of 27.3, 2.8, and 97.6 μM, respectively[1][2]. |
| Synonyms | NSC 170724; 5-(2-Nitrovinyl)benzodioxole |
| MWt | 193.16 |
| Formula | C₉H₇NO₄ |